CCL19 and graft versus host disease: FRC-specific deletion of DLL1/4 in Ccl19-Cre+ FRCs abrogates the production of pathogenic cytokines and expression of gut-homing integrins by alloimmune T cells, limiting intestinal inflammation and preventing GVHD (Chung et al., 2017; Tkachev et al., 2023).